| - GRCh37:
- Chr7:116411709
- GRCh38:
- Chr7:116771655
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr7:116418889
- GRCh38:
- Chr7:116778835
| MET | F1134I, F1152I, F704I | Papillary renal cell carcinoma type 1 | Uncertain significance
(May 5, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156756605
- GRCh38:
- Chr1:156786813
| PRCC | S241L | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116411908
- GRCh38:
- Chr7:116771854
| MET | G535S, G965S, G983S | Papillary renal cell carcinoma type 1, Autosomal recessive nonsyndromic hearing loss 97, Osteofibrous dysplasia,
Hepatocellular carcinoma, Renal cell carcinoma, Hereditary cancer-predisposing syndrome
| Uncertain significance
(Mar 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116380118
- GRCh38:
- Chr7:116740064
| MET | L73V, L503V | Renal cell carcinoma, Papillary renal cell carcinoma type 1 | Uncertain significance
(Jul 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116411649
- GRCh38:
- Chr7:116771595
| MET | T513I, T943I, T961I | Renal cell carcinoma, Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1
| Conflicting interpretations of pathogenicity
(Jul 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:116339133-116399550
| MET | | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Aug 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116380900-116381085
| MET | | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Aug 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436127
- GRCh38:
- Chr7:116796073
| MET | N1392K, N1374K, N944K | Papillary renal cell carcinoma type 1, Hepatocellular carcinoma, Autosomal recessive nonsyndromic hearing loss 97,
Osteofibrous dysplasia, Renal cell carcinoma, Hereditary cancer-predisposing syndrome
| Uncertain significance
(Jul 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116417482
- GRCh38:
- Chr7:116777428
| MET | N1118S, N670S, N1100S | Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1 | Uncertain significance
(Sep 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116438325
- GRCh38:
- Chr7:116798271
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116438278
- GRCh38:
- Chr7:116798224
| MET | | Papillary renal cell carcinoma type 1 | Benign
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116438107
- GRCh38:
- Chr7:116798053
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436981
- GRCh38:
- Chr7:116796927
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436964
- GRCh38:
- Chr7:116796910
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116312537
- GRCh38:
- Chr7:116672483
| COMETT, MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116312464
- GRCh38:
- Chr7:116672410
| COMETT, MET | | Papillary renal cell carcinoma type 1 | Benign
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116438087
- GRCh38:
- Chr7:116798033
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116438056
- GRCh38:
- Chr7:116798002
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116438049
- GRCh38:
- Chr7:116797995
| MET | | Papillary renal cell carcinoma type 1 | Benign
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116437892
- GRCh38:
- Chr7:116797838
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436708
- GRCh38:
- Chr7:116796654
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436671
- GRCh38:
- Chr7:116796617
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436658
- GRCh38:
- Chr7:116796604
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436616
- GRCh38:
- Chr7:116796562
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436575
- GRCh38:
- Chr7:116796521
| MET | | Papillary renal cell carcinoma type 1 | Benign
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116415152
- GRCh38:
- Chr7:116775098
| MET | E1082D, E1100D, E652D | Papillary renal cell carcinoma type 1, Renal cell carcinoma, Hereditary cancer-predisposing syndrome
| Uncertain significance
(May 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339985
- GRCh38:
- Chr7:116699931
| MET | S283P | Inborn genetic diseases, Papillary renal cell carcinoma type 1 | Uncertain significance
(Jun 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116437815
- GRCh38:
- Chr7:116797761
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116437655
- GRCh38:
- Chr7:116797601
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116437537
- GRCh38:
- Chr7:116797483
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436554
- GRCh38:
- Chr7:116796500
| MET | | Papillary renal cell carcinoma type 1 | Benign
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436537
- GRCh38:
- Chr7:116796483
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436474
- GRCh38:
- Chr7:116796420
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436379
- GRCh38:
- Chr7:116796325
| MET | | Papillary renal cell carcinoma type 1 | Benign
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116409788
- GRCh38:
- Chr7:116769734
| MET | | Papillary renal cell carcinoma type 1, not specified, Renal cell carcinoma,
Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity
(Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:116312611
- GRCh38:
- Chr7:116672557
| COMETT, MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116438423
- GRCh38:
- Chr7:116798369
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116438380
- GRCh38:
- Chr7:116798326
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116437422
- GRCh38:
- Chr7:116797368
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116437422
- GRCh38:
- Chr7:116797368
| MET | | Papillary renal cell carcinoma type 1 | Benign
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116437411
- GRCh38:
- Chr7:116797357
| MET | | Papillary renal cell carcinoma type 1 | Benign
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436205
- GRCh38:
- Chr7:116796151
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436180
- GRCh38:
- Chr7:116796126
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116380061
- GRCh38:
- Chr7:116740007
| MET | H484Y, H54Y | Renal cell carcinoma, Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome
| Uncertain significance
(Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116403249
- GRCh38:
- Chr7:116763195
| MET | H855R, H407R, H837R | Papillary renal cell carcinoma type 1, not specified, Renal cell carcinoma
| Uncertain significance
(Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339129-117307172
| CFTR, ASZ1, CAPZA2, MET, RNU2-1, ST7, ST7-OT3, ST7-OT4, WNT2 | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jun 19, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116339129-116436188
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Apr 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116380896-116436188
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Mar 20, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116339139-116340348
| MET | | Renal cell carcinoma, Papillary renal cell carcinoma type 1 | Uncertain significance
(Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116339584
- GRCh38:
- Chr7:116699530
| MET | N149S | Renal cell carcinoma, Osteofibrous dysplasia, Autosomal recessive nonsyndromic hearing loss 97,
Papillary renal cell carcinoma type 1, Hepatocellular carcinoma, Hereditary cancer-predisposing syndrome
| Uncertain significance
(Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339505
- GRCh38:
- Chr7:116699451
| MET | D123N | Papillary renal cell carcinoma type 1, Renal cell carcinoma, not provided,
Hereditary cancer-predisposing syndrome | Uncertain significance
(Jun 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116381005
- GRCh38:
- Chr7:116740951
| MET | D113N, D543N | Renal cell carcinoma, Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity
(Feb 21, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:116436145
- GRCh38:
- Chr7:116796091
| MET | D1380E, D1398E, D950E | Papillary renal cell carcinoma type 1 | Uncertain significance
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116422193
- GRCh38:
- Chr7:116782139
| MET | | Papillary renal cell carcinoma type 1 | Likely benign
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116411907
- GRCh38:
- Chr7:116771853
| MET | | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Jul 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116409698
- GRCh38:
- Chr7:116769644
| MET | | Papillary renal cell carcinoma type 1 | Likely benign
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116409676
- GRCh38:
- Chr7:116769622
| MET | | Autosomal recessive nonsyndromic hearing loss 97, not provided, Papillary renal cell carcinoma type 1,
not specified | Benign
(Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116403083
- GRCh38:
- Chr7:116763029
| MET | | Papillary renal cell carcinoma type 1, not specified | Likely benign
(Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116398511
- GRCh38:
- Chr7:116758457
| MET | | Papillary renal cell carcinoma type 1 | Likely benign
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116381138
- GRCh38:
- Chr7:116741084
| MET | | Papillary renal cell carcinoma type 1 | Benign
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116381121-116381122
- GRCh38:
- Chr7:116741067-116741068
| MET | | not provided, Papillary renal cell carcinoma type 1, not specified
| Benign
(Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116380003
- GRCh38:
- Chr7:116739949
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116380002
- GRCh38:
- Chr7:116739948
| MET | | Papillary renal cell carcinoma type 1 | Likely benign
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116339548
- GRCh38:
- Chr7:116699494
| MET | N137S | Papillary renal cell carcinoma type 1 | Uncertain significance
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:11308103
- GRCh38:
- Chr1:11248046
| MTOR | D297N | Papillary renal cell carcinoma type 1, not specified, not provided
| Conflicting interpretations of pathogenicity
(Feb 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:11288729
- GRCh38:
- Chr1:11228672
| MTOR | R1009Q | Papillary renal cell carcinoma type 1 | Pathogenic
(May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116339390
- GRCh38:
- Chr7:116699336
| MET | | Renal cell carcinoma, Papillary renal cell carcinoma type 1 | Likely benign
(May 28, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339189
- GRCh38:
- Chr7:116699135
| MET | | Papillary renal cell carcinoma type 1 | Likely benign
(Dec 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116339738
- GRCh38:
- Chr7:116699684
| MET | | Renal cell carcinoma, Hereditary cancer-predisposing syndrome, not provided,
Papillary renal cell carcinoma type 1 | Conflicting interpretations of pathogenicity
(Aug 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:116397835
- GRCh38:
- Chr7:116757781
| MET | | Renal cell carcinoma, Papillary renal cell carcinoma type 1 | Conflicting interpretations of pathogenicity
(Oct 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:10191534-10191540
- GRCh38:
- Chr3:10149850-10149856
| LOC107303340, VHL | R136fs, R177fs | Von Hippel-Lindau syndrome, Papillary renal cell carcinoma type 1, Skin adenoma,
Cerebellar hemangioblastoma | Pathogenic
(Aug 16, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr7:116436123
- GRCh38:
- Chr7:116796069
| MET | D1391G, D1373G, D943G | not provided, Renal cell carcinoma, Hereditary cancer-predisposing syndrome,
Papillary renal cell carcinoma type 1 | Conflicting interpretations of pathogenicity
(Oct 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:116397699
- GRCh38:
- Chr7:116757645
| MET | V228A, V658A | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Conflicting interpretations of pathogenicity
(Aug 31, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:116414997
- GRCh38:
- Chr7:116774943
| MET | M1049V, M601V, M1031V | Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome, not provided,
Renal cell carcinoma | Uncertain significance
(Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116411929
- GRCh38:
- Chr7:116771875
| MET | D990N, D542N, D972N | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116411932
- GRCh38:
- Chr7:116771878
| MET | A991T, A543T, A973T | Papillary renal cell carcinoma type 1 | Uncertain significance
(Dec 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116395399-116395579
- GRCh38:
- Chr7:116755345-116755525
| MET | | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Nov 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116436046
- GRCh38:
- Chr7:116795992
| MET | E1365D, E1347D, E917D | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jul 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116435996
- GRCh38:
- Chr7:116795942
| MET | S1349A, S1331A, S901A | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116435788
- GRCh38:
- Chr7:116795734
| MET | T1311S, T1293S, T863S | Hereditary cancer-predisposing syndrome, not provided, Papillary renal cell carcinoma type 1,
Renal cell carcinoma | Uncertain significance
(Sep 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116412010
- GRCh38:
- Chr7:116771956
| MET | E1017Q, E569Q, E999Q | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jul 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116409787
- GRCh38:
- Chr7:116769733
| MET | A909G, A891G, A461G | Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1 | Uncertain significance
(Dec 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116409696
- GRCh38:
- Chr7:116769642
| MET | | Papillary renal cell carcinoma type 1 | Likely benign
(Jul 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116398512
- GRCh38:
- Chr7:116758458
| MET | | Papillary renal cell carcinoma type 1 | Likely benign
(Jul 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116397494
- GRCh38:
- Chr7:116757440
| MET | L622F, L192F | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jul 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116381018
- GRCh38:
- Chr7:116740964
| MET | R547Q, R117Q | Renal cell carcinoma, not provided, Papillary renal cell carcinoma type 1,
Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity
(Mar 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:116380119
- GRCh38:
- Chr7:116740065
| MET | L503Q, L73Q | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jul 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116380107
- GRCh38:
- Chr7:116740053
| MET | N499S, N69S | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116340063
- GRCh38:
- Chr7:116700009
| MET | T309P | Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1, Renal cell carcinoma
| Uncertain significance
(Jun 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339866
- GRCh38:
- Chr7:116699812
| MET | D243G | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Jul 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339707
- GRCh38:
- Chr7:116699653
| MET | D190G | Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1, Renal cell carcinoma
| Uncertain significance
(Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339443
- GRCh38:
- Chr7:116699389
| MET | S102N | Papillary renal cell carcinoma type 1, Renal cell carcinoma | Uncertain significance
(Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339374
- GRCh38:
- Chr7:116699320
| MET | Q79R | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jul 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116339353
- GRCh38:
- Chr7:116699299
| MET | V72A | Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1, Renal cell carcinoma
| Uncertain significance
(Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339273
- GRCh38:
- Chr7:116699219
| MET | N45K | Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1 | Uncertain significance
(Mar 20, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339129-116340348
- GRCh38:
- Chr7:116699075-116700294
| MET | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Jun 18, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116339129-117144427
- GRCh38:
- Chr7:116699075-117504373
| LOC126860157, LOC126860158, LOC123956215, ASZ1, CAPZA2, CFTR, LOC111365177, LOC111674463, LOC111674464, LOC111674465, LOC111674466, LOC111674476, LOC111674478, LOC113219431, LOC113219432, LOC113219433, LOC113219434, LOC113219439, LOC113219440, LOC113219442, LOC113219443, LOC113219444, LOC113219445, LOC113219446, LOC113219447, LOC116186911, LOC126860159, LOC129999177, LOC129999178, LOC129999179, LOC129999180, LOC129999181, LOC129999182, LOC129999183, LOC129999184, LOC129999185, LOC129999186, LOC129999187, LOC129999188, MET, MIR6132, ST7, ST7-AS1, ST7-AS2, ST7-OT3, ST7-OT4, WNT2 | | Papillary renal cell carcinoma type 1 | Uncertain significance
(Apr 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr7:116395479
- GRCh38:
- Chr7:116755425
| MET | R591Q, R161Q | Hereditary cancer-predisposing syndrome, Papillary renal cell carcinoma type 1, Renal cell carcinoma
| Uncertain significance
(May 30, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:116339900
- GRCh38:
- Chr7:116699846
| MET | E254D | Hereditary cancer-predisposing syndrome, Renal cell carcinoma, not provided,
Papillary renal cell carcinoma type 1, Hepatocellular carcinoma, Osteofibrous dysplasia,
Autosomal recessive nonsyndromic hearing loss 97, Papillary renal cell carcinoma type 1 | Uncertain significance
(Nov 9, 2022) | criteria provided, multiple submitters, no conflicts |